UK to launch new adverse events reporting system:
This article was originally published in Clinica
The National Patient Safety Agency, an independent body due to be launched in July, will operate a new adverse events reporting system. Its aim will be to ensure that "lessons learnt are properly shared with the whole of the health service", the Department of Health has said. It will run parallel to that operated by the MDA to record manufacturers' reports.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.